October 20, 2011
Next-Gen Sequencing Enters the Clinical Space
- clinical next generation sequencing,
- Sanger sequencing,
- microarray, and
- cytogenetic analyses
Our comprehensive test panels allow for cost effective and efficient analysis of clinically actionable biomarkers spanning a wide range of diseases. We currently offer a specialized oncology test panel for a number of solid tumor and hematologic malignancies directly applicable to diagnosis and prognosis (click here to see our Services). The analysis of the disease-specific gene targets, when considered with other pathology findings, aids in the stratification of disease and elucidates optimal treatment strategies. Expert faculty members from the Departments of Genetics and Pathology are available for clinical testing guidance and consultation. Please contact us for further information.